Asia Pacific Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country
Market Introduction
Drug delivery is an engineered technology that is implemented in medical devices to inject drugs or chemicals into the body. These technologies are used to enhance efficacy, drug absorption, and recovery rate. A few types of the drug delivery systems available in the market include transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular. Drug delivery systems are primarily used to control the rate of drug release or targeted delivery of various therapeutic agents to treat multiple diseases or improve the health of the patients.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific pharmaceutical drug delivery market is expected to reach US$ 473,700.1 Mn by 2027 from US$ 277,589.9 Mn in 2019. The market is anticipated to grow at a CAGR of 7.1% from 2020 to 2027. Factors driving the market growth include the increasing shortage of medicines. However, the low R&D funding activities by governments in developing economies restrain the market growth.
Key Market Segments
By route of administration, the injectable drug delivery segment accounted for the largest share of the Asia Pacific pharmaceutical drug delivery market in 2018. In terms of application, the cancer segment held the largest share of the market in 2018. In terms of end users, the hospitals segment held the most significant share of the pharmaceutical drug delivery market in Asia Pacific in 2018.
Major Sources and Companies Listed
Several major primary and secondary sources studied to building report on pharmaceutical drug delivery market in Asia Pacific are Chinese Academy of Sciences (CAS), Australian Research Council (ARC), Centers For Disease Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), Ministry of Health and Prevention (MoHAP), Ministry of Health and Family Welfare (MoHFW), and others.
Reasons to buy report
- It provides understanding of the Asia Pacific, push to talk market landscape and identifies market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific push to talk market.
- It helps efficiently plan merger and acquisition, and partnership deals in the Asia Pacific pharmaceutical drug delivery market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of market performance of various segments pertaining to the Asia Pacific push to talk market.
- It provides market revenue forecast of the market based on various segments for the period from 2018 to 2027.
ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Country
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
Company Profiles
- 3M
- Antares Pharma
- Bayer AG
- BD
- GlaxoSmithKline plc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Pharmaceutical Drug Delivery Market – By Route of Administration
1.3.2 Asia Pacific Pharmaceutical Drug Delivery Market – By Application
1.3.3 Asia Pacific Pharmaceutical Drug Delivery Market – By End User
1.3.4 Asia Pacific Pharmaceutical Drug Delivery Market – By Country
2. Asia Pacific Pharmaceutical Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Pharmaceutical Drug Delivery Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 4.2.1 Asia Pacific Pharmaceutical Drug Delivery Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Pharmaceutical Drug Delivery Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Shortage of Medicines
5.2 Key Restraints
5.2.1 Low R&D Funding by Government in Developing Economies
5.3 Key Market Opportunities
5.3.1 Growing Emerging Markets
5.4 Future Trend
5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis
6. Pharmaceutical Drug Delivery Market – Asia Pacific Analysis
6.1 Asia Pacific Pharmaceutical Drug Delivery Market Revenue Forecasts and Analysis
7. Pharmaceutical Drug Delivery Market Analysis – By Route of Administration
7.1 Overview
7.2 Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
7.3 Oral Drug Delivery
7.3.1 Overview
7.3.2 Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Injectable Drug Delivery
7.4.1 Overview
7.4.2 Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Ocular Drug Delivery
7.6.1 Overview
7.6.2 Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Pulmonary Drug Delivery
7.7.1 Overview
7.7.2 Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Nasal Drug Delivery
7.8.1 Overview
7.8.2 Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Transmucosal Drug Delivery
7.9.1 Overview
7.9.2 Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.10 Implantable Drug Delivery
7.10.1 Overview
7.10.2 Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Drug Delivery Market Analysis – By Application
8.1 Overview
8.2 Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Cancer
8.4.1 Overview
8.4.2 Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Cardiovascular Diseases
8.5.1 Overview
8.5.2 Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Diabetes
8.6.1 Overview
8.6.2 Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Respiratory Diseases
8.7.1 Overview
8.7.2 Respiratory Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Central Nervous System Disorders
8.8.1 Overview
8.8.2 Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Autoimmune Diseases
8.9.1 Overview
8.9.2 Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.10 Other Diseases
8.10.1 Overview
8.10.2 Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Pharmaceutical Drug Delivery Market Analysis – By End User
9.1 Overview
9.2 Asia Pacific Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 ASCs/ Clinics
9.5.1 Overview
9.5.2 ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Other End Users
9.6.1 Overview
9.6.2 Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Asia Pacific Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.4 Asia Pacific Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.5 Asia Pacific Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 Asia Pacific: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 China: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 China: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 China Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 China Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 China Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Japan: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Japan: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Japan Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Japan Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Japan Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 India: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 India: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 India Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 India Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 India Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.10 South Korea: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 South Korea: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 South Korea Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 South Korea Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.10.4 South Korea Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.11 Australia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Australia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Australia Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Australia Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Australia Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Drug Delivery Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 3M
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Antares Pharma
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bayer AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GlaxoSmithKline plc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. China Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 5. China Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. China Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Japan Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. India Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. India Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. India Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. South Korea Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 14. South Korea Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. South Korea Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Australia Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 17. Australia Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. Australia Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Glossary of Terms, Pharmaceutical Drug Delivery market
LIST OF FIGURES
Figure 1. Asia Pacific Pharmaceutical Drug Delivery Market Segmentation
Figure 2. Asia Pacific Pharmaceutical Drug Delivery Market Overview
Figure 3. Injectable Drug Delivery Segment Held Largest Share of Product Segment in Pharmaceutical Drug Delivery Market
Figure 4. China Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Pharmaceutical Drug Delivery Market- Leading Country Markets (US$ Mn)
Figure 6. Asia Pacific Pharmaceutical Drug Delivery Market - Asia Pacific PEST Analysis
Figure 7. Asia Pacific Pharmaceutical Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Pharmaceutical Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 10. Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
Figure 19. Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Respiratory Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Asia Pacific Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027 (%)
Figure 28. Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Asia Pacific: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 33. Asia Pacific Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 34. Asia Pacific: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 35. China: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Japan: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. India: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. South Korea: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Australia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
The List of Companies - Asia Pacific Pharmaceutical Drug Delivery Market
- 3M
- Antares Pharma
- Bayer AG
- BD
- GlaxoSmithKline plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific pharmaceutical drug delivery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific pharmaceutical drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.